Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3Adenoma 2Rectal Neoplasms 1Neoplasms 1Cystic Fibrosis 1Colonic Neoplasms 1

Interventions

Bevacizumab 119Fluorouracil 91Leucovorin 83Cetuximab 83Oxaliplatin 80pembrolizumab 70Irinotecan 67Nivolumab 46Capecitabine 43Specimen Handling 40regorafenib 30Folfox protocol 29trifluridine tipiracil drug combination 28Magnetic Resonance Spectroscopy 27Biopsy 27Panitumumab 26Standard of Care 25HMPL-013 25IFL protocol 21Gemcitabine 20Blood Specimen Collection 19atezolizumab 18Trifluridine 18Cisplatin 18tislelizumab 17balstilimab 16Colonoscopy 16Carboplatin 16encorafenib 15Paclitaxel 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Occult Blood × 1 year × Clear all
NCT01538550 2026-04-14

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

Norwegian Institute of Public Health

Phase NA Active not recruiting
140,000 enrolled
Gastrointestinal

Adenoma, Neoplasms, Colorectal Neoplasms

NCT05362344 2026-03-24

NICE-CF

University of Washington, the Collaborative Health Studies Coordinating Center

Active not recruiting
350 enrolled
Gastrointestinal

Adenoma, Cystic Fibrosis, Colorectal Neoplasms

NCT00102011 2026-03-09

00-046

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
4,952 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡